ATLANTA — The fourth American aid worker sickened with the Ebola virus arrived Tuesday morning to a mostly calm scene at Emory University Hospital, where two others have been successfully treated.
An ambulance carrying the patient arrived about 10:25 a.m. (1425 GMT), with a police escort. Wearing a bulky protective suit similar to those of Emory’s first two arrivals, the patient walked from the ambulance to the hospital. Reporters and television cameras, but fewer curious onlookers, gathered in clusters along the street.
About an hour earlier, the specially equipped plane that has carried all three Emory patients touched down at an air base just northwest of Atlanta.
Hospital officials didn’t release the patient’s identity or status, but the World Health Organization says a doctor who had been working in an Ebola treatment center in Sierra Leone tested positive for the disease.
At a news conference, Dr. Aneesh Mehta said the patient’s ability to walk from the ambulance was a good sign, but not the only factor the hospital must consider.
The medical team will evaluate the patient’s overall health and consider all treatment options, said Mehta, an infectious disease expert at Emory. He would not elaborate.
The special isolation unit that will house the patient can hold up to three people, and that capacity could be increased if needed, Mehta said.
The Ebola outbreak sweeping West Africa has killed more than 2,200 people and has taken a particularly high toll on health care workers. Last month, two U.S. workers who contracted Ebola in Liberia, Dr. Kent Brantly and Nancy Writebol, were treated successfully at Emory.
Another worker, Dr. Rick Sacra, 51, is being treated at the Nebraska Medical Center in Omaha. He is in stable condition. Federal officials say they asked that hospital to treat him instead of Emory to prepare other isolation units for more Ebola patients if needed.
Brantly and Writebol were given the experimental drug ZMapp. Both credited the drug with helping their recovery, but there is no way to know its effects. Sacra is being treated with a different experimental drug. His doctors have refused to name it but say they’ve been consulting with experts on Ebola.
Details of the latest patient’s treatment are not known, but ZMapp could not have been used. Brantly and Writebol were the first to receive it; it had never been tested on humans. The rest of the limited supply was given to five others.
Once a new batch is ready, it still needs basic tests before it can be tried again, officials have said.
Talk to us
> Give us your news tips.
> Send us a letter to the editor.
> More Herald contact information.
